Similar articles

• Cardiovascular risk factors in supersonic pilots in Poland.

  Mazurek K, Wielgosz A, Efenberg B, Orzel A. Mazurek K, et al. Aviat Space Environ Med. 2000 Dec;71(12):1202-5. Aviat Space Environ Med. 2000. PMID: 11439719
• Cholesterol, cholesterol lowering agents/statins, and urologic disease: part II--do you know your Framingham Risk Score?

  Moyad MA, Merrick GS. Moyad MA, et al. Urol Nurs. 2006 Jun;26(3):227-9, 203. Urol Nurs. 2006. PMID: 16800331 No abstract available.
• Genetics and molecular biology: rationale for targeting high-density lipoprotein cholesterol for therapeutic intervention.

  Mukherjee S. Mukherjee S. Curr Opin Lipidol. 2006 Oct;17(5):602-5. doi: 10.1097/01.mol.0000245265.93999.ef. Curr Opin Lipidol. 2006. PMID: 16960508 No abstract available.
• Understanding cholesterol and its role in heart disease.

  Evered A. Evered A. Nurs Times. 2007 Jan 9-15;103(2):28-9. Nurs Times. 2007. PMID: 17278732 Review.
• Stricter cholesterol guidelines broaden indications for the 'statin' drugs.

  Capriotti T. Capriotti T. Medsurg Nurs. 2003 Feb;12(1):51-7. Medsurg Nurs. 2003. PMID: 12619600 Review. No abstract available.